A panel convened by the Advanced Technologies & Treatments for Diabetes Congress issued new time-in-range recommendations for type 1 and type 2 diabetes patients using a continuous glucose monitoring device. The recommendations, presented at the American Diabetes Association annual meeting and published in Diabetes Care, cover most diabetes patients, pregnant or older patients or those at high hypoglycemia risk.
Panel releases new time-in-range recommendations for CGM use
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.